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 2009 WILEY-VCH Verlag GmbIn recent decades, biomedical researchers have increasingly
realized the importance of local interactions between synthetic
materials and cells for their macroscopic functionality.[1–3] The
groundbreaking progress in the biological sciences has led to a
push towards custom-tailored biomaterials with precisely designed
physico-chemical properties at the nano- and microscale.[3–5] To
date, a range of different approaches towards custom-tailored
biomaterials exist based on different types of materials, such as
hydrogels,[6,7] microfabricated biomaterials,[8–11] or electrospun
fiber scaffolds.[12–19] In addition, so-called bio-hybrid materials
have been proposed,[20] where cells and synthetic building blocks
form structurally and functionally integrated architectures.[20–24]
Bio-hybrid materials may have important advantages over
conventional biomaterials including improved cellular integration,
potentially more straightforward in vivo applicability, or the ability
to effectively remodel their materials structure with time. While
bio-hybrid materials have so far been realized mostly as 2D cell
sheets,[20–22] a next generation of integrated biomaterials may be
contemplated, where both synthetic building blocks, such asmicro-
or nanoparticles, and cells become integral structural elements that
ultimately form the actual biomaterial through directional self-
assembly in all three dimensions.[23–24] In fact, entirely different
biomaterials may be created based on well-ordered assemblies of
cells and synthetic building blocks, as long as the synthetic building
blocks can be designed to undergo spatially directed association
with cells. In this respect, novel nano- and microparticle designs
will have to be realized that are structurally anisotropic and, at the
same time, show spatially-controlled affinity towards cells. When
designing synthetic building blocks for such bio-hybrid materials,
not only the chemical make-up of bulk and interfaces have been
appreciated as important design criteria for biomaterials but alsophysical properties, such as microstructure, anisotropic particle
architecture, or shape.[3] While the potential of sophisticated
bio-hybrid materials may be vast, with applications in areas
ranging from novel actuators to tissue engineering and medical
imaging, actual implementation has often been impeded by the
lack of appropriate synthetic routes towards anisotropic building
blocks. Only recently, a range of synthetic concepts has been
developed for the fabrication of anisotropic particles,[25] including
microfluidic technologies,[26–30] microfabrication,[31] continuous-
flow polymerization,[32] self-assembly,[33] or electrohydrodynamic
co-jetting.[34–39]
Herein, we report initial work towards a novel type of
microstructured bio-hybrid material comprised of anisotropic
polymer particles with spatially-controlled affinity towards human
endothelial cells (Scheme 1a). These anisotropic particles consist of
two distinct compartments that can exhibit vastly different
functions. Here, functional bipolarity is realized by selective
surface modification to create polymer particles with two
biologically distinguishable hemispheres: one exhibiting high
binding affinity for human endothelial cells and the other being
essentially resistant towards cell binding (Scheme 1).
Bicompartmental particles were synthesized by simultaneous
electrohydrodynamic co-jetting of two different solutions of
polyacrylamide/poly(acrylic acid) co-polymers (PAAm-co-AA,
Scheme 1b). While the base polymers were generally the same
for both hemispheres, different functional groups were selectively
incorporated into compartments to enable subsequent surface
modifications. For instance, PAAm-co-AA polymers modified with
biotin were used as components of one of the jetting solutions,
when subsequent surface modification with streptavidin (SAv) was
intended. The biotin-modified PAAm-co-AA polymer was obtained
in a simple one-step synthesis. Carboxylic acid groups of
PAAm-co-AA were activated using 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide hydrochloride in combination with
N-hydroxysulfo-succinimide sodium salt (EDC/sulfo-NHS) as
coupling agents. After the reaction, excess reagent and urea were
removed by dialysis and the final product was lyophilized and
characterized by 1H-NMR spectroscopy (Supporting Information,
Fig. S1). Alternatively, acetylene-modified PAAm-co-AA was added
to the jetting solutions, when compartment-specific surface
modification via copper(I)-catalyzed Huisgen 1,3-dipolar cycload-
dition was intended. For this purpose, acetylene-modified
PAAm-co-AA was prepared using a method similar to the one
used for biotin modification of PAAm-co-AA. Again, free acid
groups were activated in the presence of EDC/sulfo-NHS and













Scheme 1. Synthesis and unidirectional self-assembly of bicompartmental particles. a) Scheme for the binding of bicompartmental particles to cells via
streptavidin present on the particle surface of one compartment and biotin from cell-specific antibody (in this case PECAM). b) Bicompartmental particles were
fabricated via electrohydrodynamic co-jetting of polymer solutions. Reaction schemes for the incorporation of PEG and streptavidin are shown as examples.hours, as confirmed by 1H-NMR spectroscopy (Supporting
Information, Fig. S1). Moreover, fluorescein isothiocyanate
(FITC)- or rhodamine-conjugated dextran were selectively added
to the jetting solutions to confirm particle anisotropy or to
monitor unidirectional association between particles and cells
using fluorescence imaging (Scheme 1a).[34]
In general, electrohydrodynamic co-jetting of two different
PAAm-co-AA solutions yielded particles with well-defined, sphe-
rical morphologies. Figure 1a shows a confocal laser scanning
microscopy (CLSM) image of a typical batch of bicompartmental
particles suspended in aqueous solution. The CLSM image reveals
confinement of green and red fluorescence into individual
hemispheres, suggesting the presence of two distinct compart-
ments. The presence of distinct compartments was further sup-
ported by quantitative analysis of a representative population of
bicompartmental particles via flow cytometry (Fig. 1b). In this
experiment, bicompartmental particles containing Atto 665 in one
compartment and FITC in the other compartment were compared
to bicompartmental particles without the fluorochromes or those
with either Atto 665 or FITC alone in one of the compartments. For
bicompartmental particles loaded with both fluorochromes, more
than 95% of the particle population was localized in the upper right
quadrant, indicating that the particles were indeed positive for both
Atto 665 and FITC (Fig. 1b,c). This result was in distinct differenceAdv. Mater. 2009, 21, 4920–4925  2009 WILEY-VCH Verlag Gto the remaining three particle populations, which were either
positive for Atto 665 or FITC only or did not contain any fluor-
ochrome (lower left quadrant). The flow cytometric data are in
excellent agreement with the bicompartmental nature of the
particles, as observed by CLSM (Fig. 1a), and were in general
agreement with previously reported bicompartmental particles.[34]
To stabilize the particles for subsequent surface modification and
use in physiological media, bicompartmental particles were cross-
linked via thermal imidization,[36] which resulted in particles that
formed a well-dispersed suspension and were stable over several
weeks. After surface modification with polyethylene glycol (PEG)
and streptavidin, the bicompartmental particle suspensions were
examined by CLSM. A typical CLSM image of an aqueous particle
suspension (pH¼ 7.4) is shown in Figure S2 of the Supporting
Information. Image analysis revealed an average hydrodynamic
radius of 847nmand a standard deviation of 478nm for the particles
shown in Figure S2. This is higher than comparable bicompart-
mental particles without surfacemodification, which had an average
radius of 427 234nm, determined by dynamic light scattering.[36]
Prior to studying directed interactions of bicompartmental
particles with human endothelial cells, the initial biocompatibility
of these particles was evaluated. Human umbilical vein endothelial
cells (HUVECs) were incubated with non-modified bicompart-













Figure 1. Particle characterization. a) CLSM image of bicompartment particles presenting PEG on both compartments (red and green) and streptavidin in
the compartment including rhodamine dextran (red). b) Flow cytometry analysis of bicompartmental particles. c) Graphical representation of the flow
cytometry data shown in (b). Further details are provided in the Supporting Information, Figure S3.
4922with either PEG or biotin/streptavidin for 24 or 96 hours at various
concentrations. The presence of the particles did not significantly
affect the proliferation of HUVECs, as determined by a standard
MTS assay [3-(4,5- dimethylthiazol-2- yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium] (Fig. 2a). Similarly, cell
viability evaluated using Annexin V and propidium iodide (PI) as
markers of cell apoptosis and death, respectively, revealed no
statistically significant difference in the total percentage of live
cell population after exposure to particles, as compared to cells
grown in the absence of particles. These initial biocompatibility
experiments suggest that the herein developed bicompartmental
microparticles do not appear to exhibit significant cytotoxic effects
that would result in a decrease of cell proliferation and viability. In
fact, the data obtained for surface-modified PAAm-co-AAparticles
are in general agreement with a previous analysis of short-term
biocompatibility of bicompartmental particles[37] and confirm that
the introduction of bicompartmental particles to HUVECs may be
considered safe, at least in vitro, within the particle doses and
incubation times pursued herein to form bio-hybrid materials.
To demonstrate compartment-specific association between
bicompartmental particles and human cells, particles prepared
by electrohydrodynamic co-jetting were selectively modified with
streptavidin in one hemisphere only. The selective incorporation of
biotin in one compartment was confirmed by self-assembly of
biotin with fluorescence-labeled streptavidin and subsequent
CLSM analysis (Supporting Information, Fig. S3). These particles
were then incubated under serum-free conditions with human
endothelial cells that were labeled with either biotinylated antibody
against platelet endothelial cell-adhesion molecule (PECAM),
which is highly expressed on endothelial cells including HUVECs,
or with a biotinylated isotype antibody, which exhibits only
low-level, non-specific binding to the cells. This preparation was
pursued to ensure introduction of a biotin linker, which binds to
streptavidin with exceptionally high affinity, thereby effectively
coupling cells and particles (Scheme 1). We further confirmed the
controlled binding of particles in the presence of serum, since 2009 WILEY-VCH Verlag Gmbserum contains proteins that potentially may interfere with the
ability to undergo self-assembly. In a control experiment,
monocompartmental PAAm-co-AA particles (i.e., particles with
one single compartment) were prepared by electrohydrodynamic
jetting, which contained 13% (w/w) of the biotin-modified
PAAm-co-AA polymer, and were allowed to contact surfaces that
presented the complementary binding molecule streptavidin. To
prepare these surfaces, we used chemical vapor deposition (CVD)
polymerization, which has been used previously for deposition of
reactive coatings onto flat and 3D substrates.[40–42] In this case, we
used CVD polymerization to deposit approximately 50-nm-thick
films of poly(4-heptadecafluorononanoyl-p-xylylene-co-p-xylelene),
followed by immobilization of biotin-hydrazide and streptavidin.[43]
The streptavidin-presenting substrates were incubated with
particles under serum-containing conditions (2% fetal bovine
serum, FBS). Particles without biotin ligands were used as a
reference. As shown in Figure S5 of the Supporting Information,
biotin-containing particles but not biotin-free particles bound to the
streptavidin-modified surfaces. The presence of serum did not
prevent the ability of the particles to bind to the surface as indicated
by the increase in red color for the biotin-containing particles.
Finally, particle binding to cells was assessed by flow cytometry
as the increase in cell-associated FITC fluorescence, which is
caused by cell/particle association. Initial experiments revealed
substantial non-specific binding between bicompartmental parti-
cles modified with streptavidin in one compartment and human
endothelial cells. This non-specific binding was present also with
non-modified bicompartmental particles, regardless of whether the
cells were stained with endothelial-cell-specific or with non-specific
control antibodies (Fig. 3a). The non-specific binding established a
serious challenge to further steps towards the design of
well-defined bio-hybrid materials, as the preparation of structurally
controlled bio-hybrid materials require high selectivity between
binding and non-binding particle compartments. To mitigate the
non-specific binding of particles to cells, the entire particle surface,













Figure 2. Short-term biocompatibility of bicompartmental particles with various surface modi-
fications. a) Effect of bicompartmental particles on HUVEC proliferation as measured by a
colorimetric MTS assay. b) Effect of bicompartmental particles on HUVEC viability as assessed by
flow cytometry via Annexin V/PI labeling.copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition. The cou-
pling reaction occurred between acetylene groups of acetylene-
modified PAAm-co-AA added to both jetting solutions and azide
groups introduced to PEG prior to surface coupling.[9,10] As
expected, modification of the particle surface via immobilization of
PEG significantly decreased non-specific association between
particles and cells (Fig. 3a). Moreover, streptavidin-modified
particles bound specifically to HUVECs that were labeled with
antibody against PECAM but not to cells labeled with the isotype
control antibody. The fluorescence signal for cells incubated with
the non-specific isotope antibody was not significantly different
from cell autofluorescence observed with cells in the absence of
particles. This strongly supports unidirectional association between
anisotropic particles and human endothelial cells. The flow cyto-
metric analysis was further supported by CLSM (Fig. 3b). For this
purpose, cells bound to particles were separated from free particles
by fluorescence activated cell sorting. The overlay of differential
interference contrast and fluorescent images corroborate increased
cellular binding observed with streptavidin-modified particles as
compared to particles that were not modified or presented PEG alone.
When incubated with human endothelial cells, these particles
exhibit a bipolar behavior, where one compartment exhibitsAdv. Mater. 2009, 21, 4920–4925  2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinbinding affinity towards human endothelial
cells, while the other compartment was
essentially non-binding (Fig. 3). In this design,
particles not only bound to the top of the
human endothelial cells, but associated all
around the perimeter of cells forming a single
particle lining (Fig. 4).
With the fundamental feasibility of aniso-
tropic particles for self-association with cells
demonstrated, future work will need to
diversify on the type of anisotropic building
blocks that can be designed for use in
bio-hybrid materials. An essential requirement
for bio-hybrid materials will be the availability
of synthetic building blocks that can provide
directionally controlled binding patterns at
cellular or subcellular resolution. Specifically,
controlling the number of compartments,
compartment sizes, the relative positioning
of compartments on a particle, or the
introduction of differently shaped building
blocks, such as bicompartmental rods, will
enable the synthesis of many novel bio-hybrid
architectures. Such novel type of biomaterials
may be of equal importance for medical as well
as biotechnological applications including
regenerative medicine, medical imaging, and
the design of novel actuators or power harvest-
ing and storage devices.Experimental
Materials: Poly(acrylamide-co-acrylic acid, sodium
salts) (PAAm-co-AA) (MW 200 kD, 10% acrylic
acid residues) was purchased from Polysciences
(Warrington, PA). Polyethylene glycol monomethylether mesylate (methyl-PEG-mesylate, MW 5 kD, Fluka) and sodium azide
(Sigma) were dissolved in dimethylformamide (DMF) and stirred at 60 8C
for 24 h. The polymer product was precipitated by addition of excess ethyl
ether and recovered by filtration. The filtrate was dissolved in water and
dialyzed (membrane molecular weight cut off is 3 kD) overnight and
subsequently lyophilized.
Fabrication of Bicompartmental Particles via Electrohydrodynamic
co-jetting: Bicompartmental PAAm particles were prepared by electro-
hydrodynamic co-jetting as previously described [34,36]. All components
were dissolved in double distilled (dd) H2O and reported as weight per
volume. Particles presenting acetylene groups or biotin were prepared using
the following jetting solutions, respectively, with 0.5% FITC- or rhodami-
ne-conjugated dextran: 4% PAAm-co-AA and 1% acetylene-modified
PAAm-co-AA or 3% PAAm-co-AA, 1% acetylene-modified PAAm-co-AA,
and 1% biotin-modified PAAm-co-AA. Following the electrohydrodynamic
co-jetting, particles were incubated at 175 8C for 3 h to induce thermal
imidization between carboxylic acid and amide groups.
Surface Modification of Bicompartmental Particles: Particles were
modified with PEG using a copper(I)-catalyzed Huisgen 1,3-dipolar
cycloaddition. Briefly, bicompartmental particles were suspended in dd
H2O, to which methyl-PEG-azide was added. 0.3 M sodium ascorbate and
0.03 M CuSO4 H2O were added to the suspension, and the mixture was
maintained on a hematology mixer at room temperature for 10 h. Resulting
particles were washed 3 times with dd H2O by centrifugation and finally
resuspended in phosphate buffered saline (PBS). Next, PEG-modified













Figure 3. Directional cell binding of bicompartmental particles. a) Quanti-
fication of the percent of cell population with bound bicompartmental
particles and corresponding CLSM images. /: unmodified bicompart-
mental particles, PEG/PEG: bicompartment particles with PEG on the
surface of both compartments, PEG/PEGþ SAv: bicompartment particles
with PEG on surface of both compartments with streptavidin (SAv) only on
the surface of one compartment. b) Overlays of CLSM images with
differential interference contrast images corresponding to the samples
studied by flow cytometry. All scale bars are 100mm.
Figure 4. Self-assembly of bicompartmental particles and human endo-
thelial cells. a,c) CLSM images and b,d) overlays of CLSM images with
differential interference contrast images of human endothelial cells self-
assembled with PEG/PEGþ SAv particles. Images were taken within the
same field of view at two different focal planes towards the top of the cells
(a,b) and at half cell height (c,d). All scale bars are 10mm.
4924PAAm-co-PAA were suspended in PBS and incubated with streptavidin
(Pierce, Rockford, IL) for 6 h at room temperature on a hematology mixer.
The final suspension was washed with fresh PBS 3 times and isolated by
centrifugation.
Characterization of Bicompartmental Particles: For imaging of the
particles by CLSM (SP2 CLSM, Leica, USA), a suspension of bicompart-
mental particles in water was placed between two cover slips. FITC and
rhodamine were excited with Ar/ArKr or GreNe laser at 488 nm or 543 nm,
respectively. Typical images of bicompartmental particle suspensions were
analyzed by Image J [44] to obtain size-distribution measurements
(Supporting Information, Figure S2). The errors in particle recognition by
Image J were corrected for individual particles by visual comparison with
the original image and the surface area of individual particle was converted
to the diameter assuming a perfectly spherical envelope.
Bicompartmental character of the particles was analyzed by flow
cytometry as previously described [36]. To minimize any bleed-over of
fluorescent dyes, FITC- and Atto 655-conjugated dextrans were used.
Particles without any fluorochrome, those loaded with either FITC- or Atto
655-dextran alone, or those with both fluorochrome in each compartment
were resuspended in PBS and analyzed using fluorescence-activated cell
sorting (FACSCalibur, Becton Dickinson Biosciences, San Jose, CA)
at the University of Michigan Flow Cytometry Core Facility. For each
sample, 20000 events were collected and fluorescence signals from FITC- 2009 WILEY-VCH Verlag Gmband Atto 655-conjugated dextrans were resolved in FL1 (excitation with a
488 nm laser with 530/30 bandpass filter) and FL4 (excitation with a
635 nm laser with 661/16 bandpass filter) channels, respectively. Data
acquisition was performed using CellQuest Pro (BD Biosciences) and
analysis was performed usingWinMDI (Scripps Research Institute, La Jolla,
CA, USA). Population within the first decade is considered to be negative
for the fluorescence and the double positive population in the upper right
corner is considered to be bicompartmental.
Short-Term Biocompatibility of Bicompartmental Particles: The effect of
bicompartmental particles on HUVEC proliferation was evaluated using a
commercially available colorimetric cell proliferation assay (CellTiter 96
Aqueous One Solution Cell Proliferation Assay, Promega, Madison, WI,
USA) as previously reported [37]. Briefly, particles were added to cells
cultured in Endothelial cell Growth Media containing 2% FBS (Lonza,
Basel, Switzerland) at a dose of 0.01, 0.1, or 1mg per 106 initial number of
cells seeded. At 4, 24, 48, 72, and 96 h after incubation with the
bicompartmental particles, colorimetric reagent was added for 4 h and
absorbance was measured at 490 nm using a spectrophotometric plate
reader (Molecular Dynamics).
The degree of cytotoxicity of bicompartmental particles was assessed by
viability staining using flow cytometry as previously described [37]. In brief,
HUVECs cultured in Endothelial cell Growth Media containing 2% FBS












www.advmat.de(FITC only) per 106 initially seeded cells for 24 h were stained with Alexa
fluor 647-conjugated Annexin V and PI (Invitrogen) for 30min. Samples
were analyzed by FACSCalibur. Cell population with increased fluorescence
resolved in FL1 channel (excitation by 488 nm laser, 530/30 filter) was gated
as cells with associated bicompartmental particles. Cell population that
were double negative or positive for both Annexin V (resolved in FL4,
excitation by a 635 nm laser with 661/16 filter) and PI (resolved in FL2,
excitation by a 488 nm laser with 585/42 filter) were considered to be dead
or alive, respectively.
Directional Binding of Bicompartmental Particles to Cells: Binding of
bicompartmental particles to cells was first evaluated using flow cytometry.
Human umbilical vein endothelial cells (HUVECs; p5) suspended in 0.5%
bovine serum albumin (BSA) in PBS were stained with biotin-conjugated
anti-human IgG isotype control or anti-human CD31 antibody (Southern
Biotech, Birmingham, AL) for 30min at 4 8C. Upon washing in ice-cold
buffer (PBSþ 0.5% BSA) 3 times by centrifugation, these cells were
subsequently incubated with indicated particles (0.5mg per 106 cells) for
30min at 4 8C on hematology mixer, washed, and assessed by flow
cytometry using a BD FACSCalibur (Becton Dickinson, Franklin Lakes, NJ)
and reported as percent of cell population with bound particles.
In some cases, cells bound to particles were sorted to separate
non-bound, free particles by fluorescence activated cell sorting using BD
FACSDiVa (Becton Dickinson) equipped with 3 lasers (488 nm, 350 nm,
and 633 nm). Cell population before and after sorting were viewed using an
Olympus FluoView 500 laser scanning confocal microscope (Olympus
America, Center Valley, PA) equipped with a diode laser with UV excitation
(405 nm), a multi-line argon laser (458 nm, 488 nm, and 515 nm), and two
solid-state Helium Neon lasers (543 nm and 633 nm).
Orientation of particle binding to cells was further visualized using
CLSM. HUVECs grown on poly-L-lysine coated cover slips were rinsed 3
times with D-PBS, then fixed with 4% paraformaldehyde (Sigma) and
permeabilized with 0.1% Triton X-100 (Sigma). Upon rinsing with PBS with
0.1% Tween20 (PBS-T), cells were blocked with 5% normal goat serum
(NGS) (Zymed, Carlsbad, CA) for 1 h. Cells were then stained with mouse
anti-human PECAM (Chemicon, Billerica, MA) for 1 h, followed by
biotin-conjugated goat anti-mouse IgG1 (Caltag Laboratories, Carlsbad,
CA) and in some cases also with Alexa 633-conjugated phalloidin for
30min. Cells were washed and subsequently incubated with indicated
particle suspensions on a rotator for 30min under serum-free conditions.
Loosely or non-bound particles were washed with PBS-T. Cover slips were
mounted with ProLong Gold and stained with 40,6-diamidino-
2-phenylindoldihydrochloride (DAPI, Invitrogen, Carlsbad, CA) and stored
overnight at 4 8C and imaged using an Olympus FluoView 500 laser
scanning confocal microscope (Olympus America).
Statistical Analysis: Statistical analysis was performed using a general
linear model ANOVA with Minitab software (Version 15, Minitab, State
College, PA, USA). Unless otherwise indicated, p-values of 0.05 were
considered significant. Experiments were repeated as indicated.Acknowledgements
M. Y. and K. H. R. contributed equally to this work. Supporting Information
is available online from Wiley InterScience or from the author.
Received: June 12, 2009
Published online: September 18, 2009[1] N. A. Peppas, R. Langer, Science 1994, 263, 1715.
[2] R. Langer, D. A. Tirrell, Nature 2004, 428, 487.
[3] S. Mitragotri, J. Lahann, Nat. Mater. 2009, 8, 15.Adv. Mater. 2009, 21, 4920–4925  2009 WILEY-VCH Verlag G[4] M. Yoshida, R. Langer, A. Lendlein, J. Lahann, Polym. Rev. 2006, 46, 347.
[5] W. F. Liu, C. S. Chen, Adv. Drug Delivery Rev. 2007, 59, 1319.
[6] N. A. Peppas, J. Z. Hilt, A. Khademhosseini, R. Langer, Adv. Mater. 2006, 18,
1345.
[7] M. C. Cushing, K. S. Anseth, Science 2007, 316, 1133.
[8] V. L. Tsang, S. N. Bhatia, Adv. Drug Delivery Rev. 2004, 56, 1635.
[9] D. W. Hutmacher, J. Biomater. Sci. Polym. Ed. 2001, 12, 107.
[10] D. S. Kohane, R. Langer, Pediatr. Res. 2008, 63, 487.
[11] A. Khademhosseini, R. Langer, J. Borenstein, J. P. Vacanti, Proc. Natl. Acad.
Sci. USA 2006, 103, 2480.
[12] M. Goldberg, R. Langer, X. Q. Jia, J. Biomater. Sci. Polym. Ed. 2007, 18, 241.
[13] J. Venugopal, S. Low, A. T. Choon, S. Ramakrishna, J. Biomed. Mater. Res. B
2008, 84B, 34.
[14] I. K. Kwon, S. Kidoaki, T. Matsuda, Biomaterials 2005, 26, 3929.
[15] F. Yang, R. Murugan, S. Wang, S. Ramakrishna, Biomaterials 2005, 26,
2603.
[16] S. Bhaskar, J. Lahann, J. Am. Chem. Soc. 2009, 131, 6650.
[17] S. Y. Chew, Y. Wen, Y. Dzenis, K. W. Leong, Curr. Pharm. Des. 2006, 12,
4751.
[18] J. Xie, X. Li, Y. Xia, Macromol. Rapid Commun. 2008, 29, 1775.
[19] T. J. Sill, H. A. von Recum, Biomaterials 2008, 29, 1989.
[20] A. W. Feinberg, A. Feigel, S. S. Shevkoplyas, S. Sheeky, G. M. Whiteside,
K. K. Parker, Science 2007, 317, 1366.
[21] M. Ebara, M. Yamato, T. Aoyagi, A. Kikuchi, K. Sakai, T. Okano, Bioma-
cromolecules 2004, 5, 505.
[22] S. Okajima, Y. Sakai, T. Yamaguchi, Langmuir 2005, 21, 4043.
[23] O. Kriha, M. Becker, M. Lehmann, D. Kriha, J. Kriegelstein, M. Yosef,
S. Schlecht, R. B. Wehrspohn, J. H. Wendorff, A. Greiner, Adv. Mater. 2007,
18, 2483.
[24] A. J. Swiston, C. Cheng, S. H. Um, D. J. Irvine, R. E. Cohen, M. F. Rubner,
Nano Lett. 2008, 8, 4446.
[25] M. Yoshida, J. Lahann, ACS Nano 2008, 6, 1101.
[26] A. S. Utada, E. Lorenceau, D. R. Link, P. D. Kaplan, H. A. Stone, D. A. Weitz,
Science 2005, 308, 537.
[27] S. Q. Xu, Z. H. Nie, M. Seo, P. Lewis, E. Kumacheva, H. A. Stone,
P. Garstecki, D. B. Weibel, I. Gitlin, G. M. Whitesides, Angew. Chem.
Int. Ed. 2005, 44, 724.
[28] T. Nisisako, T. Torii, T. Takahashi, Y. Takizawa, Adv. Mater. 2006, 18, 1152.
[29] Z. H. Nie, W. Li, M. Seo, S. Q. Xu, E. Kumacheva, J. Am. Chem. Soc. 2006,
128, 9408.
[30] T. Nisikado, T. Torii, Lab on a chip 2008, 8, 287.
[31] J. P. Rolland, B. W. Maynor, L. E. Euliss, A. E. Exner, G. M. Denison,
J. M. DeSimone, J. Am. Chem. Soc. 2005, 127, 10096.
[32] D. Dendukuri, D. C. Pregibon, J. Collins, T. A. Hatton, P. S. Doyle, Nat
Mater. 2006, 5, 365.
[33] A. Walther, K. Matussek, A. H. E. Mueller, Nano 2008, 2, 1167.
[34] K.-H. Roh, D. C. Martin, J. Lahann, Nat. Mater. 2005, 4, 759.
[35] K.-H. Roh, D. C. Martin, J. Lahann, J. Am. Chem. Soc. 2006, 128, 6796.
[36] K.-H. Roh, M. Yoshida, J. Lahann, Langmuir 2007, 23, 5683.
[37] M. Yoshida, K.-H. Roh, J. Lahann, Biomaterials 2007, 28, 2446.
[38] S. Bhaskar, J. Hitt, S. W. L. Chang, J. Lahann, Angew. Chem. Int. Ed. 2009,
25, 4589.
[39] S. Bhaskar, K.-H. Roh, X. Jiang, G. A. L. Baker, J. Lahann, Macromol. Rapid
Commun. 2008, 29, 1655.
[40] J. Lahann, Polym. Int. 2006, 55, 1361.
[41] H.-Y. Chen, Y. Elkasabi, J. Lahann, J. Am. Chem. Soc. 2006, 128, 374.
[42] H. Y. Chen, J. Lahann, Anal. Chem. 2005, 77, 6909.
[43] H. Nandivada, H. Y. Chen, J. Lahann,Macromol. Rapid Commun. 2005, 26,
1794.
[44] M. D. Abramoff, P. J. Magelhaes, S. J. Ram, Biophotonics Int. 2004, 11(7),
36.mbH & Co. KGaA, Weinheim 4925
